The AHEAD 3‐45 Study: Design of a prevention trial for Alzheimer's diseaseMichael S. Rafii, Paul Aisen, Reisa A. Sperling et al.|Alzheimer s & Dementia|2022Cited by 266
Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer’s diseaseShobha Dhadda, Donald A. Berry, Michael C. Irizarry et al.|Alzheimer s Research & Therapy|2022Cited by 37